Individualized short-term therapy for adolescents impaired by ADHD despite previous routine care treatment (ESCAdol) - a randomized controlled trial within the consortium ‘ESCAlife’

Not Applicable

• Conditions: Attention deficit-/hyperactivity disorder (ADHD); F90; Hyperkinetic disorders

• Registration Number: DRKS00008974
• Lead Sponsor: niversitätsklinikum Würzburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-12-28
• Study Completion: 2021-02-02
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 157

Inclusion Criteria

ADHD according to DSM-5 criteria; diagnosis established by clinician-rated ADHD-Checklist (DCL-ADHS)
- patient has been in ADHD routine care for a minimum of 6 months
-no sufficient benefit from previous interventions developed for the treatment of ADHD children or ADHD adults (insufficient benefit defined as significant impairment by ADHD and/or co-morbid symptoms: CGI-S > 4)
- patients and primary caregiver speak sufficient German

Exclusion Criteria

- IQ < 80
- comorbidity: pervasive developmental disorder, schizophrenia, bipolar disorder, severe depressive episode
- need for inpatient treatment
- after TAU-Phase co-treatment including: a) intensive psychotherapies on a biweekly or more intense basis or b) medication which is not constant or not licensed for the treatment of ADHD and co-morbid conditions

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in blinded clinician-rated ADHD-Checklist (DCL-ADHS) scores between T2 (pre-intervention) and T3 (post-Intervention after 3 month)

Secondary Outcome Measures

Name	Time	Method
Change from T2 (pre-intervention) to T3 (post-intervention) in impairment scores on the Clinical Global Impression Scale (CGI; clinician-rated), ADHD symptoms (SBB-ADHS, FBB-ADHS; patient-, parent- and teacher-rated), symptoms of oppositional-defiant and conduct disorder (SBB-SSV, FBB-SSV, clinical interview DCL-SSV; patient-, parent- and teacher- and clinician-rated), ADHD-related functional impairment (WFIRS-P; parent-rated), internalizing and externalizing symptoms (CBCL; parent-rated),- quality-of-life (KIDSCREEN-10; patient- and parent-rated) and parenting (FZEV, FPNE, VER; parent-rated).